Market Place
Sourcing Support
From insulin to Ozempic, history of Novo Nordisk`s CEOs
19 May 2025 //
REUTERS
Novo ousts CEO after falling behind in weight loss market
17 May 2025 //
REUTERS
Lars Rebien Sørensen joins Novo Nordisk A/S board
16 May 2025 //
PR NEWSWIRE
Septerna Reports First Quarter 2025 Financial Results
15 May 2025 //
GLOBENEWSWIRE
AMTF report: Insulin unaffordable for T1D patients in LMICs
14 May 2025 //
EXPRESS PHARMA
Novo strikes $2.2B deal with Septerna to new obesity treatments
14 May 2025 //
REUTERS
Select Trial: Wegovy® reduces cardiovascular events before weight
13 May 2025 //
PR NEWSWIRE
Novo Nordisk: Sogroya effective in children with growth disorders
13 May 2025 //
GLOBENEWSWIRE
Zepbound outperforms Novo`s Wegovy for weight loss in trial
12 May 2025 //
REUTERS
Novo Nordisk A/S: Trading in shares by board members
09 May 2025 //
GLOBENEWSWIRE
Novo Nordisk hopes to see US Wegovy sales recover soon
08 May 2025 //
REUTERS
Enforcement Report - Week of May 7, 2025.pdf
07 May 2025 //
FDA
Novo Nordisk: ECO 2025 - Semaglutide data reveals health benefits
06 May 2025 //
GLOBENEWSWIRE
FDA accepts Novo`s application for oral Wegovy for weight loss
03 May 2025 //
REUTERS
Novo Nordisk: CVS Caremark selects Wegovy as preferred obesity
01 May 2025 //
PR NEWSWIRE
Essence trial, Semaglutide improves MASH in adults at 72 weeks
30 Apr 2025 //
PR NEWSWIRE
Novo Nordisk to sell Wegovy via telehealth to US customers
29 Apr 2025 //
REUTERS
Ro, NovoCare Partner to Offer Wegovy® at Lowest Price
29 Apr 2025 //
PR NEWSWIRE
Hims & Hers, Novo Nordisk Partner to Expand Access to Care
29 Apr 2025 //
BUSINESSWIRE
Novo Nordisk`s obesity drug Wegovy debuts in Thailand
29 Apr 2025 //
REUTERS
Ozempic copies restricted after US judge denies injunction
26 Apr 2025 //
REUTERS
Novo protects US patients with legal wins against compounder
25 Apr 2025 //
PR NEWSWIRE
Novo Nordisk applies for FDA approval of semaglutide obesity pill
23 Apr 2025 //
FIERCE PHARMA
Novo Nordisk discontinues India`s top-selling insulin brand
22 Apr 2025 //
ECONOMICTIMES
BMO says Lilly is pulling ahead of Novo in obesity market battle
18 Apr 2025 //
FIERCE PHARMA
OpenFold AI Research Consortium Welcomes New Members
15 Apr 2025 //
BUSINESSWIRE
Novo Nordisk warns of counterfeit Ozempic® injection in US
14 Apr 2025 //
PR NEWSWIRE
Novo Nordisk warns of counterfeit Ozempic in US
14 Apr 2025 //
REUTERS
Novo charts $1B-plus Brazilian production expansion for GLP-1s
09 Apr 2025 //
FIERCE PHARMA
Novo’S Wegovy, J&J’S Tremfya Led March Tv Ad Spending Totals
08 Apr 2025 //
FIERCE PHARMA
Novo Nordisk readies to bring weight-loss drug Wegovy to India
07 Apr 2025 //
ECONOMICTIMES
Novo`s longtime commercial strategy head hangs up gloves
04 Apr 2025 //
FIERCE PHARMA
Novo Nordisk announces changes in Executive Management
03 Apr 2025 //
GLOBENEWSWIRE
Novo`s longtime commercial strategy head hangs up the gloves
03 Apr 2025 //
FIERCE PHARMA
Novo nearly doubles earnings as Wegovy swells coffers
03 Apr 2025 //
REUTERS
SCORE analysis show semaglutide 2.4 mg reduce cardiovascular events
30 Mar 2025 //
PR NEWSWIRE
Ozempic® 1 mg improves outcomes in type 2 diabetes & PAD at Meeting
29 Mar 2025 //
PR NEWSWIRE
Novo Nordisk: Rybelsus shows superior cardiovascular event reduct
29 Mar 2025 //
GLOBENEWSWIRE
Novo to license obesity drug from Lexicon in up to $1 B deal
29 Mar 2025 //
FIERCE BIOTECH
Resolutions from the Annual General Meeting of Novo Nordisk A/S
27 Mar 2025 //
GLOBENEWSWIRE
Novo Holdings joins €23M Series A for Tribune Therapeutics
26 Mar 2025 //
PR NEWSWIRE
MUHC Foundation gets $2M for Metabolic Centre of Excellence
25 Mar 2025 //
GLOBENEWSWIRE
Novo offers cheaper Wegovy for all cash-paying patients
25 Mar 2025 //
FIERCE PHARMA
Novo licenses China-based biotech`s drug for up to $2B
25 Mar 2025 //
REUTERS
United Labs, Novo Nordisk agree on UBT251 license deal
24 Mar 2025 //
GLOBENEWSWIRE
Not a cost-cutting exercise`: Novo reshapes R&D setup
21 Mar 2025 //
FIERCE BIOTECH
Novo presents new semaglutide data at ACC 74th Scientific Sessions
17 Mar 2025 //
PR NEWSWIRE
Novo Nordisk Foundation Project Sparks Ultra-Processed Food Debate
12 Mar 2025 //
REUTERS
FDA to hold off action on weight-loss drug copies pending court ruling
11 Mar 2025 //
REUTERS
Novo’s CagriSema Shows Superior Weight Loss In Redefine 2 Trial
10 Mar 2025 //
GLOBENEWSWIRE
Novo trial with next-gen diabetes drug shows 15.7% weight loss
10 Mar 2025 //
REUTERS
Novo to sell Wegovy for $499 a month to cash-paying US customers
06 Mar 2025 //
PR NEWSWIRE
Novo Nordisk Launches "My Ozempic Era" Campaign For Patients
03 Mar 2025 //
PR NEWSWIRE
Gensaic, Novo Nordisk Partner on Next-Gen Precision Therapies
03 Mar 2025 //
BUSINESSWIRE
Novo Nordisk A/S: Annual General Meeting Notice
27 Feb 2025 //
GLOBENEWSWIRE
Novo`s Wegovy and Ozempic removed from US FDA shortage list
22 Feb 2025 //
REUTERS
FDA Confirms Wegovy & Ozempic Shortage Over, Novo Meets Demand
21 Feb 2025 //
PR NEWSWIRE
Novo alleges fraud after $1.3 B deal to buy drug from KBP Biosciences
19 Feb 2025 //
FIERCE BIOTECH
Novo Nordisk calls out dangers of compounded GLP-1s in new ad
12 Feb 2025 //
FIERCE PHARMA
Novo’s Bispecific for Hemophilia Aces Phase III Pediatric Trial
08 Feb 2025 //
BIOSPACE
